• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular mechanisums of regulation of NMDA receptor by post-synaptic density proteins

Research Project

Project/Area Number 12680755
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurochemistry/Neuropharmacology
Research InstitutionYamaguchi University

Principal Investigator

YAMADA Yasue  Yamaguchi University, School of Medicine, Research associate, 医学部, 助手 (00166737)

Co-Investigator(Kenkyū-buntansha) KO Ji-ai  Yamaguchi University, School of Medicine, Research associate, 医学部, 助手 (70314797)
KIMURA Yoshihiro  Yamaguchi University, School of Medicine, Assistant Professor, 医学部, 講師 (90301308)
INUI Makoto  Yamaguchi University, School of Medicine, Professor, 医学部, 教授 (70223237)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2001: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2000: ¥2,200,000 (Direct Cost: ¥2,200,000)
KeywordsNMPA recptor / PSD-95 / MALS-2 / PDZ proteins / Xenopus oocyte / PKC / Src / insulin / PDZ protein / グルタミン酸受容体 / Xenopus oocyte / 二電極膜電位固定法 / チロシンリン酸化酵素 / プロテインキナーゼC / 亜鉛
Research Abstract

The NMDA receptors is essential for the induction of long term potentiation (LTP) which is thought to plays a key role in synaptic plasticity underlying memory and learning. The NMDA receptor usually makes the complex with post-synaptic density proteins including PSD-95. MALS-2 and α-actinin. It is unknown how those proteins regulate the channel activity of the NMDA receptor. In this study, we examined the effects of PSD-95 on four )ε1/ζ1, ε2/ζ1, ε3/ζ1 and ε4/ζ1) subtypes of the NMDA receptor by injection of PSD-95 CRNA into Xenopus oocytes expressing the receptors. We also examined the effects of another PDZ protein, MALS-2, on the channel activity of the NMDA receptor. PSD-95 inhibited the protein kinase C (PKC) - mediated potentiation ofε1/ζ1 and ε2/ζ1 and the Src-mediated potentiation of ε1/ζ1. It has been reported that insulin potentiates the currents of the ε1/ζ1, ε2/ζ1, ε3/ζ1 and ε4/ζ1. Co-expressing of PSD-95 eliminated the insulin-induced potentiation of all four subtypes. MALS-2 dose not eliminate the potentiation of the channels by PKC, Src and insulin. We demonstrated that post-synaptic density proteins, like PSD-95 and MALS-2, functionally modulate the channel activity of NMDA receptor.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Yasue Yamada.: "PSD-95 climinates src-induced potentiation of NRI/NR2A-subtype NMDA receptor channels and reduces high-affinity zinc inhibition"Journal of Neurochemistry. (in press). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yoshihiro Kimura: "Reconstitution of the cytoplasmic interaction between phospholamban and Ca2+-ATPase of cardiac sarcoplasmic reticulum"Molecular Pharmacology. 61(3). 667-673 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Haghighi, K., et al.: "Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure"Jurnal of Biological Chemistry. 276. 24145-24152 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Zhai, J., et al.: "Cardiac-specific ovcrcxpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo"Journal of Biological Chemistry. 275. 10538-10544 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamada,Yasue: "PSD-95 eliminates src-nduced potentiation of NR1/NR2A-subtype NMDA receptor channels anu reduces high-affinity zinc inhibition"J. Neurochem. (in press). (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kimura,Yoshihiro: "Reconstitution of the cytoplasmic interaction between phospholamban and Ca2^+-ATPase of cardiac sarcoplasmic reticulum"Mol. Pharmacol. 61 (3). 667-673 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Haghighi,K.: "Superinhibition of sarcoplasmic rcticulum function by phospholamban induces cardiac contractile failure"J Biol Chem. 276. 24145-24152 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Zhai,J.: "Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo"J Biol Chem. 275. 10538-10544 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yasue Yamada: "PSD-95 eliminates src-induced potentiation of NR1/NR2A-subtype NMDA receptor channels and reduces high-affinity zinc inhibition"Journal of Neurochemistry. (in press). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yoshihiro Kimura: "Reconstitution of the cytoplasmic interaction between phospholamban and Ca2+-ATPase of cardiac sarcoplasmic reticulum"Molecular Pharmacology. 61(3). 667-673 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Haghighi.K., et al.: "Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure."Journal of Biological Chemistry. 276. 24145-24152 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Zhai,J.: "Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo."J.Biol.Chem.. 275(14). 10538-44 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Zvaritch,E.: "The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractolity."J.Biol.Chem.. 275(20). 14985-91 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2025-11-20  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi